文献速递咽喉与嗓音

良性声带病变内类固醇注射后的长期监测

Long-term Surveillance Following Intralesional Steroid Injection for Benign Vocal Fold Lesions.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2017-01-01

这项前瞻性队列研究纳入189例接受声带类固醇注射(VFSI)作为初始治疗的良性声带病变患者,通过每6个月的结构化电话访谈和病历复习进行2年长期监测。VFSI初始有效率为74.6%,6、12、18、24个月累积失败率分别为12%、17%、24%、32%;考虑初始应答后,2年后VFSI在最初189例中仍有效者为50%。作者认为VFSI对良性声带病变有益,但相当数量患者在2年内出现症状复发或接受后续干预,应在医疗决策中考虑。

要点

  • VFSI初始有效率为74.6%(141/189),中位随访19.4个月。
  • 6、12、18、24个月累积失败率分别为12%、17%、24%、32%。
  • 2年时VFSI在最初189例中仍有效者为50%。

核心结论

  • VFSI对良性声带病变有益,尤其当一线治疗不适合时;但相当数量患者在VFSI后2年内出现症状复发或接受后续干预,医疗决策时应考虑这一长期结果。

研究设计与样本

  • 前瞻性队列研究,在台湾台北一家三级转诊医学中心开展;纳入2011年8月至2013年9月期间以VFSI作为初始治疗的189例声带病变患者。
  • 所有参与者均接受VFSI;通过每6个月的结构化电话访谈和病历复习进行2年长期监测。

主要发现

  • 189例参与者中男性32例、女性157例,平均(SD)年龄39(10)岁(范围20-74岁);病变为声带小结72例、息肉72例、黏液潴留囊肿45例。
  • VFSI后141例(74.6%;男性23例、女性118例;平均年龄39岁,范围20-70岁)显示阳性应答(即临床显著症状缓解且无需额外操作)并接受长期监测;中位随访19.4个月,术后1年内失访2例。
  • VFSI后6、12、18、24个月的累积失败率(主观症状复发加二次治疗)分别为12%、17%、24%、32%。
  • 结合VFSI初始应答率(141/189,74.6%)后,VFSI在最初招募的189例患者中2年后仍有效者为50%。
  • VFSI长期有效率最高见于声带息肉(54%),其次为小结(49%)和囊肿(43%)。

临床怎么用

  • 作者认为VFSI可用于管理良性声带病变,尤其当一线治疗不适合时。
  • 作者指出长期结果明确相当数量患者在VFSI后2年内出现症状复发或接受后续干预,医疗决策时应考虑这一点。

局限性

  • 术后1年内失访2例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The short-term outcomes of vocal fold steroid injection (VFSI) are well documented. However, few studies have reported the long-term outcomes following VFSI. OBJECTIVE: To investigate the incidence rates of symptom recurrence and secondary interventions following VFSI for benign vocal fold lesions. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study was conducted at a tertiary referral medical center in Taipei, Taiwan. The cohort included 189 patients with vocal fold lesions who had received VFSI as the primary treatment between August 2011 and September 2013. EXPOSURES: All participants underwent VFSI. MAIN OUTCOMES AND MEASURES: Long-term surveillance was conducted through structured telephonic interviews and by reviewing medical charts every 6 months over a 2-year period. We assessed the 10-item voice handicap index, dysphonic symptoms, and whether the patients had received any additional interventions after the initial VFSI. RESULTS: The 189 participants (32 men and 157 women; mean [SD] age, 39 [10] years [range, 20-74 years] included patients who had undergone VFSI for vocal fold nodules (n = 72), polyps (n = 72), or mucus-retention cysts (n = 45). Following VFSI, 141 patients (74.6%; 23 men and 118 women; mean age, 39 years [range, 20-70 years]) showed positive response (ie, clinically significant symptom resolution without the need for additional procedures) and received long-term surveillance. The median follow-up period was 19.4 months, and 2 patients were lost to follow-up postoperatively within 1 year. The cumulative failure rates (subjective symptom recurrence plus secondary treatments) at 6, 12, 18, and 24 months after VFSI were 12%, 17%, 24%, and 32%, respectively. When the initial response rate to VFSI (141 of 189, 74.6%) was considered altogether, VFSI remained effective after 2 years in 50% of the initially recruited 189 patients. The highest rate of long-term effectiveness of VFSI occurred in vocal polyps (54%), followed by nodules (49%) and cysts (43%). CONCLUSIONS AND RELEVANCE: This study demonstrates that VFSI can be beneficial in managing benign vocal lesions, especially when first-line treatments are unsuitable. However, the long-term results of this study clarify that a substantial number of patients experience symptom recurrence or receive subsequent interventions within 2 years after VFSI; this should be considered in medical decision making.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Wang CT, Lai MS, Cheng PW, et al. Long-term Surveillance Following Intralesional Steroid Injection for Benign Vocal Fold Lesions. JAMA Otolaryngol Head Neck Surg. 2017. PMID: 28334309. doi:10.1001/jamaoto.2016.4418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。